LYKALABS.NS
Price:
$69.1
Market Cap:
$2.47B
Established in 1976 and headquartered in Mumbai, India, Lyka Labs Limited is a pharmaceutical firm specializing in the development, manufacturing, and marketing of a wide array of pharmaceutical formulations and active pharmaceutical ingredients (APIs). The company's extensive product portfolio addresses numerous therapeutic areas, including intensive care, gastroenterology, anti-infectives, anti-fungals, surgery, urology, wound care, anesthesia, and various dermatological and cosmeceutical applications like topical steroids, anti-acne, anti-aging, and hair care. These products are available in diverse forms, such as injections, creams, ointments, gels, and lotions. Beyond its own offerings,...[Read more]
Industry
Biotechnology
IPO Date
1996-01-01
Stock Exchange
NSE
Ticker
LYKALABS.NS
According to Lyka Labs Limited’s latest financial reports and current stock price. The company's current PE Ratio is -24.50. This represents a change of -100.05% compared to the average of 47.45K of the last 4 quarters.
The mean historical PE Ratio of Lyka Labs Limited over the last ten years is -18.30. The current -24.50 PE Ratio has changed 13.29% with respect to the historical average. Over the past ten years (40 quarters), LYKALABS.NS's PE Ratio was at its highest in in the December 2025 quarter at 189.72K. The PE Ratio was at its lowest in in the September 2022 quarter at -222.95.
Average
-18.30
Median
-10.79
Minimum
-149.93
Maximum
45.67
Discovering the peaks and valleys of Lyka Labs Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 992.22%
Maximum Annual PE Ratio = 45.67
Minimum Annual Increase = -329.18%
Minimum Annual PE Ratio = -149.93
| Year | PE Ratio | Change |
|---|---|---|
| 2026 | -16.00 | -135.03% |
| 2025 | 45.67 | -130.46% |
| 2024 | -149.93 | 556.63% |
| 2023 | -22.83 | -329.18% |
| 2022 | 9.96 | -255.36% |
| 2021 | -6.41 | 992.22% |
| 2020 | -0.59 | -95.91% |
| 2019 | -14.35 | 98.39% |
| 2018 | -7.23 | -65.95% |
| 2017 | -21.25 | -145.53% |
The current PE Ratio of Lyka Labs Limited (LYKALABS.NS) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-40.09
5-year avg
-26.63
10-year avg
-18.30
Lyka Labs Limited’s PE Ratio is less than TAKE Solutions Limited (26.15), less than SMS Lifesciences India Limited (27.68), less than TAKE Solutions Limited (26.15), less than SMS Lifesciences India Limited (28.72), less than Bafna Pharmaceuticals Limited (47.76), less than Trident Lifeline Limited (15.84), less than ZIM Laboratories Limited (105.39), less than ZIM Laboratories Limited (105.39), less than Nectar Lifesciences Limited (-0.82), less than Nectar Lifesciences Limited (-0.82),
| Company | PE Ratio | Market cap |
|---|---|---|
| 26.15 | $2.81B | |
| 27.68 | $3.93B | |
| 26.15 | $2.83B | |
| 28.72 | $4.97B | |
| 47.76 | $5.30B | |
| 15.84 | $3.10B | |
| 105.39 | $6.72B | |
| 105.39 | $6.72B | |
| -0.82 | $2.21B | |
| -0.82 | $2.14B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lyka Labs Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Lyka Labs Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Lyka Labs Limited's PE Ratio?
How is the PE Ratio calculated for Lyka Labs Limited (LYKALABS.NS)?
What is the highest PE Ratio for Lyka Labs Limited (LYKALABS.NS)?
What is the 3-year average PE Ratio for Lyka Labs Limited (LYKALABS.NS)?
What is the 5-year average PE Ratio for Lyka Labs Limited (LYKALABS.NS)?
How does the current PE Ratio for Lyka Labs Limited (LYKALABS.NS) compare to its historical average?